Tudor Investment Corp ET AL Invests $1.04 Million in LifeStance Health Group, Inc. $LFST

Tudor Investment Corp ET AL bought a new stake in shares of LifeStance Health Group, Inc. (NASDAQ:LFST) in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 189,038 shares of the company’s stock, valued at approximately $1,040,000.

Other hedge funds and other institutional investors have also modified their holdings of the company. Vident Advisory LLC increased its stake in LifeStance Health Group by 12.7% in the 2nd quarter. Vident Advisory LLC now owns 21,732 shares of the company’s stock worth $112,000 after purchasing an additional 2,447 shares in the last quarter. State of Wyoming boosted its holdings in shares of LifeStance Health Group by 3.8% in the third quarter. State of Wyoming now owns 89,927 shares of the company’s stock worth $495,000 after buying an additional 3,298 shares during the period. Legal & General Group Plc boosted its holdings in shares of LifeStance Health Group by 2.4% in the second quarter. Legal & General Group Plc now owns 144,263 shares of the company’s stock worth $746,000 after buying an additional 3,331 shares during the period. Polar Capital Holdings Plc increased its position in shares of LifeStance Health Group by 19.3% in the third quarter. Polar Capital Holdings Plc now owns 21,775 shares of the company’s stock worth $120,000 after acquiring an additional 3,525 shares in the last quarter. Finally, MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. raised its holdings in shares of LifeStance Health Group by 3.0% during the first quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 142,950 shares of the company’s stock valued at $952,000 after acquiring an additional 4,169 shares during the period. Institutional investors and hedge funds own 85.50% of the company’s stock.

LifeStance Health Group Price Performance

NASDAQ LFST opened at $6.24 on Tuesday. The company has a debt-to-equity ratio of 0.17, a current ratio of 1.65 and a quick ratio of 1.65. The firm has a market capitalization of $2.43 billion, a price-to-earnings ratio of 312.16 and a beta of 1.11. The company has a 50 day simple moving average of $6.90 and a 200-day simple moving average of $6.40. LifeStance Health Group, Inc. has a 52-week low of $3.74 and a 52-week high of $8.09.

LifeStance Health Group (NASDAQ:LFST) last announced its quarterly earnings data on Wednesday, February 25th. The company reported $0.03 EPS for the quarter, missing analysts’ consensus estimates of $0.05 by ($0.02). The company had revenue of $382.20 million for the quarter, compared to analysts’ expectations of $378.51 million. LifeStance Health Group had a net margin of 0.68% and a return on equity of 0.65%. The business’s revenue for the quarter was up 17.4% on a year-over-year basis. During the same period in the previous year, the firm posted ($0.01) earnings per share. Equities research analysts predict that LifeStance Health Group, Inc. will post -0.18 earnings per share for the current fiscal year.

LifeStance Health Group announced that its board has initiated a share repurchase plan on Wednesday, February 25th that permits the company to buyback $100.00 million in shares. This buyback authorization permits the company to reacquire up to 3.6% of its shares through open market purchases. Shares buyback plans are typically an indication that the company’s management believes its shares are undervalued.

Insider Activity

In other news, Director Darren M. Black sold 4,314,939 shares of the business’s stock in a transaction on Monday, March 2nd. The shares were sold at an average price of $7.01, for a total transaction of $30,247,722.39. Following the transaction, the director directly owned 29,209,776 shares in the company, valued at $204,760,529.76. The trade was a 12.87% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available at this link. 6.60% of the stock is owned by company insiders.

Analyst Ratings Changes

Several brokerages recently commented on LFST. Weiss Ratings upgraded shares of LifeStance Health Group from a “sell (d-)” rating to a “hold (c-)” rating in a research report on Friday, February 27th. BTIG Research lifted their price objective on shares of LifeStance Health Group from $10.00 to $11.00 and gave the stock a “buy” rating in a research report on Monday, February 2nd. Canaccord Genuity Group boosted their target price on shares of LifeStance Health Group from $9.00 to $10.00 and gave the company a “buy” rating in a research note on Thursday, February 26th. Jefferies Financial Group upgraded LifeStance Health Group to a “strong-buy” rating in a report on Thursday, March 12th. Finally, Wall Street Zen raised LifeStance Health Group from a “hold” rating to a “buy” rating in a research report on Sunday, February 8th. One research analyst has rated the stock with a Strong Buy rating, six have given a Buy rating and two have given a Hold rating to the company. According to data from MarketBeat.com, LifeStance Health Group has a consensus rating of “Moderate Buy” and an average price target of $9.83.

About LifeStance Health Group

LifeStance Health Group (NASDAQ:LFST) is a leading provider of outpatient mental health services in the United States. Headquartered in New York City, the company operates a growing network of clinics that deliver integrated, patient-centered psychological and psychiatric care. LifeStance’s mission is to expand access to high-quality mental health treatment by combining evidence-based therapy modalities with personalized treatment plans.

The company’s service offerings include individual, family, and group psychotherapy, psychiatric medication management, psychological assessment, and telehealth services.